Contact us : info@bioworlde.com
Home > Product > COVID-19&Infectious disease series
Tick-borne encephalitis virus E protein ectodomain(TBEV-E) NCP0158
  • Tick-borne encephalitis virus E protein ectodomain, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
Product NameTick-borne encephalitis virus E protein ectodomain(TBEV-E)
Catalog No.NCP0158
Swiss-ProtJX498940.1
Host His-tag
ReactivityE. coli Expression
ApplicationsReseach
Application_allReseach
BiowMW288bp;11kDa
Purification&PurityTransferred into competent cells and the supernatant was purified by NI column affinity chromatography and the purity is > 85% (by SDS-PAGE).
Browse similar products>>
Size Price
100ug $398
1mg $2980
Add to cart My orders
Product Name :
Tick-borne encephalitis virus E protein ectodomain(TBEV-E)
Background :
Tick-borne encephalitis virus is a flavivirus that is transmitted by Ixodes spp ticks in a vast area from western Europe to the eastern coast of Japan. Tick-borne encephalitis causes acute meningoencephalitis with or without myelitis. Morbidity is age dependent, and is highest in adults of whom half develop encephalitis. A third of patients have longlasting sequelae, frequently with cognitive dysfunction and substantial impairment in quality of life. The disease arises in patchy endemic foci in Europe, with climatic and ecological conditions suitable for circulation of the virus.
Product :
Inclusion body;0.5mol Urea,PH=8
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
Carrier:pET30a-TBEV-E-His(C-term) Virus:Tick-borne encephalitis virus strain Sofjin polyprotein gene, complete cds
Immunogen :
pathway :
  • Tick-borne encephalitis virus E protein ectodomain, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
Blocking peptide available as NCP0158P
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER